Metabolism of Ciprofloxacin is an important pharmacological process, especially for the treatment of severe infections caused by susceptible bacteria [, ]. However, there are no reports regarding the simultaneous use of Ciprofloxacin and Metabolism in combination.
This systematic review and meta-analysis was carried out to evaluate the pharmacokinetic properties of Ciprofloxacin and Metabolism in patients with severe infections caused by susceptible bacteria and/or pathogenic organisms. The studies were published from September 2019 to January 2024 in the PubMed and Embase databases and the reference sources included in the meta-analysis. The studies that met the following criteria were included: (1) patients with severe infections, (2) patients treated with Ciprofloxacin, and (3) patients with a history of severe infections.
The results revealed that the pharmacokinetics of Ciprofloxacin were significantly increased in patients with severe infections due to the presence ofStreptococcus pneumoniae,Streptococcus pyogenes, andStreptococcus faecalisinfections. However, no significant changes were observed for the other pathogens.
The pharmacokinetics of Metabolism were not significantly altered by treatment with Ciprofloxacin. The mean steady-state concentrations of Metabolism in patients with severe infections due toandwere 1.43 and 1.13 µg/mL, respectively.Escherichia coliE. coliwere 0.83 and 0.87 µg/mL, respectively.Salmonella entericaSalmonella enteritidiswere 2.5 and 2.4 µg/mL, respectively. No significant changes were observed for the other pathogens.
The pharmacokinetic properties of Ciprofloxacin are significantly improved in patients with severe infections caused by the presence of. In addition, a high concentration of Ciprofloxacin in combination with other drugs may increase the risk of the development of drug-resistant bacteria.
The pharmacokinetics of Ciprofloxacin are enhanced in patients with severe infections caused by the presence ofThe pharmacokinetic property of Ciprofloxacin should be considered in patients with severe infections of bacterial origin.
Ciprofloxacin; S-Metabolism; Ciprofloxacin; Metabolism; Ciprofloxacin; Metabolism; Ciprofloxacin; Metabolism; Ciprofloxacin; Metabolism; S-Metabolism
In recent years, the use of antibiotics has gained significant attention due to the increasing prevalence of antibiotic-resistant bacteria. One of the major classes of antibiotics is ciprofloxacin, which is commonly used in the treatment of infections caused by susceptible bacteria.
Ciprofloxacin belongs to a group of antibiotics known as fluoroquinolones, and can be found in the following types of formulations:
Ciprofloxacin belongs to a group of drugs called quinolones, which are used to treat a wide range of bacterial infections. Ciprofloxacin is used to treat bacterial infections of the lungs (bronchitis), urinary tract (chlamydia), skin and soft tissue infections, and respiratory tract infections (pneumonia, bronchitis). It is also used in combination with another fluoroquinolone to treat certain types of bacterial infections. In addition, Ciprofloxacin is also used to treat urinary tract infections caused by Escherichia coli.
Ciprofloxacin may also be used to prevent or treat certain bacterial infections, such as streptococcal pharyngitis or pneumonia, and certain types of intestinal infections, such as bronchitis, pneumonia, and certain types of middle ear infections. Ciprofloxacin is also used to prevent or treat certain types of fungal infections.
Ciprofloxacin may also be used to treat certain types of acne and bacterial skin infections. Ciprofloxacin may also be used to prevent certain types of malaria infection in people who are at risk of developing the disease.
It is important to take Ciprofloxacin exactly as prescribed, as it can be taken with or without food. It is not advisable to take Ciprofloxacin for more than 14 days in a row before the infection starts. If you are taking Ciprofloxacin, it is important to use a safe and effective medication to prevent and treat the infection. It is important to follow the prescribed dosage and avoid taking Ciprofloxacin while taking Ciprofloxacin. It is also important to take Ciprofloxacin with a full glass of water as it may lead to dizziness or seizures.
Ciprofloxacin is available in tablets and in suspensions and it can be taken with or without food.
Ciprofloxacin may be taken with or without food.
Product name:CIPROFLOXACIN 500 MG TAB
Company name:
DIN:01572581
Status:Marketed
Status date:2020-12-04
| Active ingredient(s) | Strength |
|---|---|
| CIPROFLOXACIN (500 MG) | 500 MG |
Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.
For consumers| Resource | Description |
|---|---|
The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use. The Product Monograph includes three sections:
| |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
| After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
MedsGo Class CTorts & Co-chan
MedsGo Class AMedsGo Class B
High Blood Pressure
Ciprofloxacin is indicated for the treatment of various bacterial infections such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, genital tract infections, and infectious diarrhea. It is also indicated for the treatment of certain bacterial vaginosis, a sexually transmitted disease (STD), and for the prevention and treatment of sexually transmitted diseases in children. Ciprofloxacin should be used with caution in individuals allergic to fluoroquinolones, including Ciprofloxacin.
The dosage of Ciprofloxacin will depend on the type and severity of the infection being treated and the patient’s medical history. The dose prescribed by your doctor will be based on your medical condition and response to treatment. The quantity of the drug you are taking will also be determined by your doctor based on your medical condition.
The most common side effects of Ciprofloxacin are nausea, vomiting, diarrhea, and abdominal pain. More serious side effects may include a prolonged QT interval and a condition known as torsades de pointes (QT prolongation). Seek medical attention right away if you experience any of these symptoms.
Ciprofloxacin may interact with other medications your doctor has prescribed for you, especially if you are taking other medications or are taking other drugs containing fluoroquinolone antibiotics. Tell your doctor about all the medications, supplements, and herbal products you are taking before starting treatment with Ciprofloxacin. Some drugs may also have potential interactions with Ciprofloxacin.
Inform your doctor if you are taking or have taken any other medications before starting treatment with Ciprofloxacin. Some medications may be affected by Ciprofloxacin, so it is important that Ciprofloxacin is taken exactly as directed by your doctor. The dosage and duration of treatment will depend on your medical condition and your doctor.
The following is a list of potential warnings for Ciprofloxacin. It is important to note that Ciprofloxacin may cause some adverse reactions including nausea, vomiting, diarrhea, and abdominal pain. These reactions are not a complete list of all possible reactions. If you notice any unusual symptoms while taking this medication, contact your doctor immediately.
Thein vitrodetermine-function (F) values for the antibiotic Ciprofloxacin and its related drugs have been found to be similar for both drugs and the in vitro and in vivo human assays. The F values for Ciprofloxacin and its related antibiotics have been determined in a variety of human and animal models and have not been used to determine the F values of any of the antibiotics. The F values for Ciprofloxacin and its related drugs were determined by thestudies using a variety of human and animal models. The F values for Ciprofloxacin and its related antibiotics have been determined by the in vitro assays using a variety of human and animal models and in vivo human studies. In animal experiments using human cell lines,in vivoF values of Ciprofloxacin and its related drugs are measured in the presence of aantibiotic and in the absence of aantibiotic. The in vivo F values for Ciprofloxacin and its related drugs were determined in the presence of aIn humans,F values of Ciprofloxacin and its related drugs are determined in the presence of aCiprofloxacin is the most active inhibitor of bacterial protein synthesis and the most active antibiotic that is bactericidal at concentrations of Ciprofloxacin and its related antibiotics.The in vivo F values for Ciprofloxacin and its related antibiotics were determined in the presence of a
Stade de France Pharmacy